Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-cd9895bd7-p9bg8 Total loading time: 0 Render date: 2024-12-26T04:34:05.046Z Has data issue: false hasContentIssue false

Case 25 - Not all child’s play: a path to pediatric stability

Published online by Cambridge University Press:  19 October 2021

By
Joseph Wong ,
Justine Ku  and
Takesha Cooper
Edited by
Takesha Cooper ,
Gerald Maguire  and
Stephen Stahl
Takesha Cooper
Affiliation:
University of California, Riverside
Gerald Maguire
Affiliation:
University of California, Riverside
Stephen Stahl
Affiliation:
University of California, San Diego
Get access

Summary

Pretest self-assessment question (answer at the end of the case)

Type
Chapter
Information
Case Studies: Stahl's Essential Psychopharmacology , pp. 291 - 306
Publisher: Cambridge University Press
Print publication year: 2021

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

de Miranda, AS, de Miranda, AS, Teixeira, AL. Lamotrigine as a mood stabilizer: insights from the pre-clinical evidence. Expert Opinion on Drug Discovery 2019; 14:179–90, https://doi.org/10.1080/17460441.2019.1553951CrossRefGoogle Scholar
Anon, . Drugs for ADHD. Med Lett Drugs Ther 2020; 62:9–15.Google Scholar
Biederman, J, Mick, E, Hammerness, P, et al. Open-label, 8-week trial of olanzapine and risperidone for the treatment of bipolar disorder in preschool-age children. Biol Psychiatry 2005; 58: 589–94. https://doi.org/10.1016/j.biopsych.2005.03.019Google Scholar
Biederman, J, Joshi, G, Mick, E, et al. A prospective open-label trial of lamotrigine monotherapy in children and adolescents with bipolar disorder. CNS Neurosci Ther 2010; 16:91–102. https://doi.org/10.1111/j.1755-5949.2009.00121.xCrossRefGoogle ScholarPubMed
Carandang, C, Robbins, D, Mullany, E, et al. Lamotrigine in adolescent mood disorders: a retrospective chart review.J Can Acad Child Adolesc Psychiatry 2007; 16:1–8.Google ScholarPubMed
Cerullo, MA, Strakowski, SM. A systematic review of the evidence for the treatment of acute depression in bipolar I disorder. CNS Spectr 2013; 18:199–208. https://doi.org/10.1017/S1092852913000102Google Scholar
Connolly, KR, Thase, MD. The clinical management of bipolar disorder: a review of evidence-based guidelines. Prim Care Companion CNS Disord 2011; 13:PCC.10r0109. https://doi.org/10.4088/PCC.10r01097Google ScholarPubMed
DelBello, MP, Goldman, R, Phillips, D, et al. Efficacy and safety of lurasidone in children and adolescents with bipolar I depression: a double-blind, placebo-controlled study. J Am Acad Child Adolesc Psychiatry 2017; 56:1015–25. https://doi.org/10.1016/j.jaac.2017.10.006CrossRefGoogle ScholarPubMed
Findling, RL., Landbloom, RL., Szegedi, A., et al. Asenapine for the acute treatment of pediatric manic or mixed episode of bipolar I disorder. J Am Acad Child Adolesc Psychiatry 2015; 54:1032–41. https://doi.org/10.1016/j.jaac.2015.09.007Google Scholar
Fountoulakis, KN, Kasper, S, Andreassen, O, et al. Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry. Eur Arch Psychiatry Clin Neurosci. 2012; 262 (Suppl. 1): 1–48. https://doi.org/10.1007/s00406-012-0323-xCrossRefGoogle ScholarPubMed
Fountoulakis, KN, Kontis, D, Gonda, X, et al. Treatment of mixed bipolar states. Int J Neuropsychopharmacol. 2012; 15:1015–26. https://doi.org/10.1017/S1461145711001817CrossRefGoogle ScholarPubMed
Frazier, JA, Biederman, J, Tohen, M, et al. A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder. J Child Adolesc Psychopharmacol 2001; 11:239–50. https://doi.org/10.1089/10445460152595568Google Scholar
Fusar-Poli, P, Howes, O, Bechdolf, A, Borgwardt, S. Mapping vulnerability to bipolar disorder: a systematic review and meta-analysis of neuroimaging studies. J Psychiatry Neurosci 2012; 37:170–84. https://doi.org/10.1503/jpn.110061CrossRefGoogle ScholarPubMed
Goldberg, JF Bowden, CL Calabrese, JR et al. Six-month prospective life charting of mood symptoms with lamotrigine monotherapy versus placebo in rapid cycling bipolar disorder. Biol Psychiatry 2008; 63:125–30. https://doi.org/10.1016/j.biopsych.2006.12.031Google Scholar
Goodwin, GM, Consensus Group of the British Association for Psychopharmacology. Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2009; 23:346–88. https://doi.org/10.1177/0269881109102919Google Scholar
Lewitzka, U, Severus, E, Bauer, R, et al. The suicide prevention effect of lithium: more than 20 years of evidence – a narrative review. Int J Bipolar Disord 2015; 3:32. https://doi.org/10.1186/s40345-015-0032-2Google Scholar
Musetti, L, Del Grande, C, Marazziti, D, Dell’Osso, L. Treatment of bipolar depression. CNS Spectr 2013; 18:177–87. https://doi.org/10.1017/S1092852912001009Google Scholar
Pavuluri, MN, Henry, DB, Moss, M, et al. Effectiveness of lamotrigine in maintaining symptom control in pediatric bipolar disorder. J Child Adolesc Psychopharmacol 2009; 19:75–82. https://doi.org/10.1089/cap.2008.0107Google Scholar
Praharaj, SK, Jana, AK, Goyal, N, Sinha, VK. Metformin for olanzapine-induced weight gain: a systematic review and meta-analysis. Br J Clin Pharmacol 2011; 71:377–82. https://doi.org/10.1111/j.1365-2125.2010.03783.xGoogle Scholar
Stahl, SM. Stahl’s Essential Psychopharmacology: Neuroscientific Basis and Practical Applications, 4th edn. New York, NY: Cambridge University Press, 2013.Google Scholar
Stahl, SM. Stahl’s Essential Psychopharmacology: Prescriber’s Guide, 5th edn. New York, NY: Cambridge University Press, 2014.Google Scholar
Tohen, M, Kryzhanovskaya, L, Carlson, G, et al. Olanzapine versus placebo in the treatment of adolescents with bipolar mania. Am J Psychiatry 2007; 164:1547–56. https://doi.org/10.1176/appi.ajp.2007.06111932Google Scholar
Vázquez, M, Maldonado, C, Guevara, N, et al. Lamotrigine–valproic acid interaction leading to Stevens–Johnson syndrome. Case Rep Med 2018; 2018:5371854. https://doi.org/10.1155/2018/5371854Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×